Membres
Michael White
Responsable de Structure
Responsable
Publications
Télécharger-
2021Investigating differences in village-level heterogeneity of malaria infection and household risk factors in Papua New Guinea., Sci Rep 2021 Aug; 11(1): 16540.
-
2021Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France., EBioMedicine 2021 Jul; 70(): 103495.
-
2021Kinetics of the SARS-CoV-2 antibody response and serological estimation of time since infection., J Infect Dis 2021 Jul; (): .
-
2021IgG Antibody Responses Are Preferential Compared With IgM for Use as Serological Markers for Detecting Recent Exposure to Plasmodium vivax Infection., Open Forum Infect Dis 2021 Jun; 8(6): ofab228.
-
2021Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies., Cell Rep Med 2021 May; 2(5): 100275.
-
2021Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study., PLoS Med 2021 Apr; 18(4): e1003535.
-
2021Development and validation of an in silico decision-tool to guide optimisation of intravenous artesunate dosing regimens for severe falciparum malaria patients., Antimicrob Agents Chemother 2021 Mar; (): .
-
2021Fine-scale spatio-temporal mapping of asymptomatic and clinical P. falciparum infections: epidemiological evidence for targeted malaria elimination interventions., Clin Infect Dis 2021 Mar; (): .
-
2021PvMSP8 as a Novel Plasmodium vivax Malaria Sero-Marker for the Peruvian Amazon., Pathogens 2021 Mar; 10(3): .
-
2021Novel anti-malarial drug strategies to prevent artemisinin partner drug resistance: A model-based analysis., PLoS Comput Biol 2021 Mar; 17(3): e1008850.
-
+Voir la liste complète de publications